The Enterprise Value as of December 2025 (TTM) for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is 343.36M

According to BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 343.36M. This represents a change of -15.36% compared to the average of 405.66M of the last 4 quarters.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Historical Enterprise Value (quarterly & annually)

How has BML.WA Enterprise Value performed in the past?

The mean historical Enterprise Value of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. over the last ten years is 248.09M. The current 343.36M Enterprise Value has changed 13.74% with respect to the historical average. Over the past ten years (40 quarters), BML.WA's Enterprise Value was at its highest in in the September 2020 quarter at 1.06B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Average Enterprise Value

How has BML.WA Enterprise Value performed in the past?

The current Enterprise Value of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Enterprise Value vs. Peers

How is BML.WA’s Enterprise Value compared to its peers?

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s Enterprise Value is less than KGHM Polska Miedz S.A. (54.71B), less than Allegro.eu S.A. (32.85B), less than Polski Koncern Naftowy ORLEN Spólka Akcyjna (115.92B), less than Powszechny Zaklad Ubezpieczen S.A. (64.39B), less than CD Projekt S.A. (24.79B),

Build a custom stock screener for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.